234 related articles for article (PubMed ID: 18687709)
1. Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies.
Suzuki S; Satoh T; Sato S; Otomo M; Hirayama Y; Sato H; Kawai M; Ishihara T; Suzuki N; Kuwana M
Rheumatology (Oxford); 2008 Oct; 47(10):1539-42. PubMed ID: 18687709
[TBL] [Abstract][Full Text] [Related]
2. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
Kao AH; Lacomis D; Lucas M; Fertig N; Oddis CV
Arthritis Rheum; 2004 Jan; 50(1):209-15. PubMed ID: 14730618
[TBL] [Abstract][Full Text] [Related]
3. Comment on: Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies.
Liewluck T
Rheumatology (Oxford); 2009 Jan; 48(1):90; author reply 90-1. PubMed ID: 18984607
[No Abstract] [Full Text] [Related]
4. Clinical implications of autoantibody screening in patients with autoimmune myositis.
Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
[TBL] [Abstract][Full Text] [Related]
5. Myopathy associated with anti-signal recognition peptide antibodies: clinical heterogeneity contrasts with stereotyped histopathology.
Dimitri D; Andre C; Roucoules J; Hosseini H; Humbel RL; Authier FJ
Muscle Nerve; 2007 Mar; 35(3):389-95. PubMed ID: 17143889
[TBL] [Abstract][Full Text] [Related]
6. Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.
Benveniste O; Drouot L; Jouen F; Charuel JL; Bloch-Queyrat C; Behin A; Amoura Z; Marie I; Guiguet M; Eymard B; Gilbert D; Tron F; Herson S; Musset L; Boyer O
Arthritis Rheum; 2011 Jul; 63(7):1961-71. PubMed ID: 21400483
[TBL] [Abstract][Full Text] [Related]
7. Anti-signal recognition particle autoantibody ELISA validation and clinical associations.
Aggarwal R; Oddis CV; Goudeau D; Fertig N; Metes I; Stephens C; Qi Z; Koontz D; Levesque MC
Rheumatology (Oxford); 2015 Jul; 54(7):1194-9. PubMed ID: 25524922
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients.
Suzuki S; Nishikawa A; Kuwana M; Nishimura H; Watanabe Y; Nakahara J; Hayashi YK; Suzuki N; Nishino I
Orphanet J Rare Dis; 2015 May; 10():61. PubMed ID: 25963141
[TBL] [Abstract][Full Text] [Related]
9. Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups.
Sarkar K; Weinberg CR; Oddis CV; Medsger TA; Plotz PH; Reveille JD; Arnett FC; Targoff IN; Genth E; Love LA; Miller FW
Arthritis Rheum; 2005 Aug; 52(8):2433-8. PubMed ID: 16052581
[TBL] [Abstract][Full Text] [Related]
10. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
Chahin N; Engel AG
Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720
[TBL] [Abstract][Full Text] [Related]
11. Juvenile polymyositis or paediatric muscular dystrophy: a detailed re-analysis of 13 cases.
D'Arcy CE; Ryan MM; McLean CA
Histopathology; 2009 Oct; 55(4):452-62. PubMed ID: 19817896
[TBL] [Abstract][Full Text] [Related]
12. [Anti-SRP myopathy].
Suzuki S
Rinsho Shinkeigaku; 2011 Nov; 51(11):961-3. PubMed ID: 22277439
[TBL] [Abstract][Full Text] [Related]
13. [Anti-signal recognition particle autoantibody positive myopathy].
Bodoki L; Vincze M; Hortobágyi T; Griger Z; Csonka T; Dankó K
Ideggyogy Sz; 2014 Sep; 67(9-10):347-53. PubMed ID: 25518264
[TBL] [Abstract][Full Text] [Related]
14. Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome.
Suzuki S; Hayashi YK; Kuwana M; Tsuburaya R; Suzuki N; Nishino I
Arch Neurol; 2012 Jun; 69(6):728-32. PubMed ID: 22332183
[TBL] [Abstract][Full Text] [Related]
15. Clinical and histological findings associated with autoantibodies detected by RNA immunoprecipitation in inflammatory myopathies.
Suzuki S; Yonekawa T; Kuwana M; Hayashi YK; Okazaki Y; Kawaguchi Y; Suzuki N; Nishino I
J Neuroimmunol; 2014 Sep; 274(1-2):202-8. PubMed ID: 25064497
[TBL] [Abstract][Full Text] [Related]
16. A pediatric patient with myopathy associated with antibodies to a signal recognition particle.
Kawabata T; Komaki H; Saito T; Saito Y; Nakagawa E; Sugai K; Sasaki M; Hayashi YK; Nishino I; Momomura M; Kizawa T; Imagawa T; Yokota S
Brain Dev; 2012 Nov; 34(10):877-80. PubMed ID: 22436377
[TBL] [Abstract][Full Text] [Related]
17. An unusual association: anti-Jo1 and anti-SRP antibodies in the serum of a patient with polymyositis.
Vincze M; Molnár PA; Tumpek J; Szollosi L; Gyetvai A; Kapitány A; Dankó K
Clin Rheumatol; 2010 Jul; 29(7):811-4. PubMed ID: 20221841
[TBL] [Abstract][Full Text] [Related]
18. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
[TBL] [Abstract][Full Text] [Related]
19. Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP).
Arlet JB; Dimitri D; Pagnoux C; Boyer O; Maisonobe T; Authier FJ; Bloch-Queyrat C; Goulvestre C; Heshmati F; Atassi M; Guillevin L; Herson S; Benveniste O; Mouthon L
Neuromuscul Disord; 2006 May; 16(5):334-6. PubMed ID: 16616848
[TBL] [Abstract][Full Text] [Related]
20. Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies.
Takada T; Hirakata M; Suwa A; Kaneko Y; Kuwana M; Ishihara T; Ikeda Y
Mod Rheumatol; 2009; 19(2):156-64. PubMed ID: 19089533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
